142 related articles for article (PubMed ID: 15945446)
1. [Efficiency of the clinical use of short-term controlled treatment (DOTS) in patients with new-onset destructive pulmonary tuberculosis].
Petrenko VM; Litvinenko NA
Probl Tuberk Bolezn Legk; 2005; (3):16-20. PubMed ID: 15945446
[TBL] [Abstract][Full Text] [Related]
2. [Dynamics of the release of bacilli and the closing of caverns in newly identified tuberculosis patients undergoing different chemotherapeutic regimens].
Muratov VV; Pashkov IuN; Pospelov VV
Probl Tuberk; 1981 Dec; (12):30-4. PubMed ID: 6801646
[No Abstract] [Full Text] [Related]
3. [The course of a process and the efficiency of treatment of pulmonary tuberculosis patients excreting Mycobacterium tuberculosis with extensive drug resistance to antituberculous drugs].
Mishin VIu; Komissarova OG; Chukanov VI; Kononets AS
Probl Tuberk Bolezn Legk; 2009; (2):50-2. PubMed ID: 19382643
[TBL] [Abstract][Full Text] [Related]
4. [Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
Belianin II; Shmelev EI
Probl Tuberk Bolezn Legk; 2007; (2):31-8. PubMed ID: 17419333
[TBL] [Abstract][Full Text] [Related]
5. Relationship between sputum smear grading and smear conversion rate and treatment outcome in the patients of pulmonary tuberculosis undergoing dots--a prospective cohort study.
Tiwari S; Kumar A; Kapoor SK
Indian J Tuberc; 2012 Jul; 59(3):135-40. PubMed ID: 23362709
[TBL] [Abstract][Full Text] [Related]
6. [Caseous pneumonia: diagnosis, clinical aspects and treatment].
Mishin VIu
Probl Tuberk; 2001; (3):22-9. PubMed ID: 11508227
[TBL] [Abstract][Full Text] [Related]
7. Short-course chemotherapy in pulmonary tuberculosis. A controlled trial by the British Thoracic and Tuberculosis Association.
Lancet; 1975 Jan; 1(7899):119-24. PubMed ID: 46047
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic value of bacterial isolation in destructive pulmonary tuberculosis].
Krasnoborova SIu; Kostina GI
Probl Tuberk; 2002; (11):24. PubMed ID: 12501791
[No Abstract] [Full Text] [Related]
9. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
Zhangireev AA; Ismailov ShSh; Berikova EM
Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
[TBL] [Abstract][Full Text] [Related]
10. Time to sputum conversion in smear positive pulmonary TB patients on category I DOTS and factors delaying it.
Parikh R; Nataraj G; Kanade S; Khatri V; Mehta P
J Assoc Physicians India; 2012 Aug; 60():22-6. PubMed ID: 23405517
[TBL] [Abstract][Full Text] [Related]
11. [Dynamics of the excretion of the bacilli in patients with destructive pulmonary tuberculosis under the effect of long-term tuberculostatic therapy].
Fisher EF; Velichko SA; Sharaburova OE; Strelis AK
Lab Delo; 1973; 6():340-2. PubMed ID: 4129386
[No Abstract] [Full Text] [Related]
12. [Fully supervised ambulatory short-course chemotherapy with an intermittent regimen for newly diagnosed smear-positive pulmonary tuberculosis].
Xu RX
Zhonghua Jie He He Hu Xi Za Zhi; 1987 Oct; 10(5):261-3, 307. PubMed ID: 3131029
[No Abstract] [Full Text] [Related]
13. [Dynamics of isolation of mycobacterium tuberculosis during 2-stage standard chemotherapy].
Khomenko AG; Vasil'eva IA
Probl Tuberk; 1996; (6):52-4. PubMed ID: 9019772
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of ofloxacin (zanocin) in the treatment of multidrug resistant pulmonary tuberculosis].
Mishin VIu; Vasil'eva IA
Antibiot Khimioter; 2003; 48(8):7-10. PubMed ID: 14722936
[TBL] [Abstract][Full Text] [Related]
15. [Primary drug resistance of Mycobacterium tuberculosis in patients with new-onset destructive pulmonary tuberculosis].
Zinov'ev IP; Esaulova NA; Novikov VG; Kokovikhina IA
Probl Tuberk Bolezn Legk; 2009; (4):37-9. PubMed ID: 19514452
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of culture and biological studies of patients with destructive pulmonary tuberculosis undergoing chemotherapy].
Pashkov IuN; Lobchenko AI; Stadnikova AV
Lab Delo; 1978; (12):732-4. PubMed ID: 82669
[No Abstract] [Full Text] [Related]
17. [Treatment of tuberculosis patients with massive bacterial excretion].
Gavril'ev SS; Vinokurova MK
Probl Tuberk; 1997; (2):17-8. PubMed ID: 9235572
[TBL] [Abstract][Full Text] [Related]
18. [Sparfloxacin in combined therapy for pulmonary tuberculosis].
Sokolova GB; Khaĭmenova TIu; Lazareva IaV; Khaĭmenov AIa
Antibiot Khimioter; 2008; 53(5-6):21-7. PubMed ID: 19069178
[TBL] [Abstract][Full Text] [Related]
19. [Tuberculosis of the bone].
Panek B; Chyczewska E
Pneumonol Alergol Pol; 2001; 69(11-12):673-6. PubMed ID: 12134445
[TBL] [Abstract][Full Text] [Related]
20. [Efficiency of treatment for recurrent tuberculosis and its influencing factors].
Il'ina TIa; Zhangireev AA; Sidorenko OA
Tuberk Biolezni Legkih; 2009; (12):38-42. PubMed ID: 20099386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
